Milestone Scientific Inc. (MLSS)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 5 | 10 | 9 | 10 | 9 | 9 | 9 | 10 |
| Operating profit | $m | -6 | -4 | ||||||
| Net profit | $m | -7 | -7 | -9 | -7 | -5 | -6 | -4 | -3 |
| EPS reported | $ | -0.07 | -0.05 | ||||||
| Operating cashflow per share | $ | -0.04 | -0.01 | ||||||
| Capex per share | $ | 0.00 | 0.00 | ||||||
| FCF per share | $ | -0.04 | -0.01 | ||||||
| Free cash flow | $m | -3 | -1 | ||||||
| Net debt | $m | -0 | -2 | ||||||
| Book value equity | $m | 3 | 3 | ||||||
| Book value per share | $ | 0.03 | 0.04 | ||||||
| Number of shares | m | 82.06 | 93.13 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 7.97 | 6.45 | ||||||
| P/S LTM | x | 2.50 | 2.38 | ||||||
| P/FCF LTM | x | -7.64 | -34.86 | ||||||
| EV/EBITDA LTM | x | -4.05 | -5.65 | ||||||
| EV/Sales LTM | x | 2.49 | 4.49 | ||||||
| Earnings Yield LTM | % | -25.54% | -8.99% | ||||||
| FCF Yield | % | -13.09% | -2.87% | ||||||
| Quality | |||||||||
| ROE | % | -203.45% | -149.08% | ||||||
| ROIC | % | -1.49% | -1.00% | ||||||
| Operating margin | % | -63.48% | -43.56% | ||||||
| Gross margin | % | +70.53% | +69.61% | ||||||
| FCF/Sales | % | -32.67% | -6.82% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +3.99% | +9.17% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -2.87 | -1.04 | ||||||
| Net Debt/EBITDA | x | 0.02 | 0.37 | ||||||
| EBIT/Net interest | x | -222.53 | -97.35 | ||||||
| Net debt/market cap | % | +3.57% | +1.41% | ||||||
| Net debt/Equity | x | -0.11 | -0.46 | ||||||
| Gross debt/equity | x | 0.36 | 0.18 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Milestone Scientific Inc. is dedicated to the innovation, refinement, and global distribution of advanced diagnostic and therapeutic injection technologies and devices. These solutions cater to the medical, dental, and cosmetic industries, with a presence in the United States, China, and other international markets. The company's operations are divided into two main segments: Dental and Medical. Within its Dental division, key products include CompuDent and the STA Single Tooth Anesthesia System, both instrumental for delivering local anesthetics across all dental procedures. For broader applications, the firm offers CompuFlo, a sophisticated computer-controlled system capable of delivering drugs, anesthetics, and other medicaments comfortably and precisely, as well as aspirating bodily fluids or prior injections. Complementing this, a disposable injection handpiece provides precise tactile control during administration. In the Medical segment, Milestone Scientific introduces the CompuFlo Epidural, a computer-guided anesthesia system designed for a variety of medical applications. Additionally, their CompuMed system is utilized in numerous specialized procedures, including plastic surgery, hair restoration, colorectal surgery, podiatry, dermatology, and orthopedics, among others. Headquartered in Livingston, New Jersey, Milestone Scientific Inc. was established in 1989.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Milestone Scientific Inc. is dedicated to the innovation, refinement, and global distribution of advanced diagnostic and therapeutic injection technologies and devices. These solutions cater to the medical, dental, and cosmetic industries, with a presence in the United States, China, and other international markets. The company's operations are divided into two main segments: Dental and Medical. Within its Dental division, key products include CompuDent and the STA Single Tooth Anesthesia System, both instrumental for delivering local anesthetics across all dental procedures. For broader applications, the firm offers CompuFlo, a sophisticated computer-controlled system capable of delivering drugs, anesthetics, and other medicaments comfortably and precisely, as well as aspirating bodily fluids or prior injections. Complementing this, a disposable injection handpiece provides precise tactile control during administration. In the Medical segment, Milestone Scientific introduces the CompuFlo Epidural, a computer-guided anesthesia system designed for a variety of medical applications. Additionally, their CompuMed system is utilized in numerous specialized procedures, including plastic surgery, hair restoration, colorectal surgery, podiatry, dermatology, and orthopedics, among others. Headquartered in Livingston, New Jersey, Milestone Scientific Inc. was established in 1989.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free